CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum

Loading

CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum

BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will showcase its digital health portfolio and host a symposium which addresses barriers in access to transplantation at the 31st Annual UNOS Transplant Management Forum (TMF) taking place May 16-18 in Denver, Colorado. CareDx is the leading Diamond level sponsor of this year’s UNOS TMF.

“Improving the transplant journey is at the heart of everything we do, and we are thrilled to showcase how our investment in cutting-edge digital health solutions is making a meaningful impact across the board with ever-increasing adoption,” said Kashif Rathore, Chief of Patient and Digital Solutions at CareDx. “CareDx is proud to participate in this important yearly forum to demonstrate how our connected set of transplant management solutions enables more cohesive care in the complex transplant ecosystem.” Read the complete press release on CareDx.com.

Loading

Algorithm Predicts Post-Transplantation Survival

Loading

A machine-learning algorithm could offer personalized predictions of life expectancy following lung transplantation, research suggests.

The random survival forests (RSF) model had “excellent performance” in predicting both survival overall and at the specific time points of one month and a year, revealed the researchers. Read more in Inside Precision Medicine.

Loading

One in 10 solid organ transplant recipients develops bacteremia 1 year after transplant

Loading

By Caitlyn Stulpin

Nearly 10% of solid organ transplant recipients may develop bacteremia in the first year after transplant, according to a study published in Open Forum Infectious Diseases.

“There are limited contemporary robust data on the epidemiology of bacteremia during the first fragile year after a solid organ transplantation,” Dionysios Neofytos, MD, specialist in the division of infectious diseases at the University Hospital of Geneva, told Healio. Read more in Healio.

Loading

Most adults with diabetes report CGM disruptions due to device problems, medical care

Loading

By Michael Monostra
More than 80% of adults with diabetes using continuous glucose monitoring reported at least one instance of needing to stop using their device due to medical care or a device-related problem, according to survey findings.

“CGM disruption is the rule rather than the exception,” Alexis M. McKee, MD, CDCES, assistant professor of medicine at Washington University School of Medicine in St. Louis, told Healio. Read the full story in Healio.

Loading

How one woman’s selfless act to donate a kidney led her to the top of the world

Loading

In 2021 Maureen Murphy answered the call to give a part of herself–literally. When she found out her friend Kim Moulton needed a kidney transplant, she offered to be her donor. “I had everything I needed in life, so I thought this was something I could do to help,” Maureen says. She contacted the Dartmouth Hitchcock Transplant center, where Kim was a patient of Michael Daily, MD, section chief of Solid Organ Transplantation at Dartmouth Hitchcock Medical Center, and told them she wanted to donate one of her kidneys to Kim. Read more in Dartmouth Health.

Loading

GIVING HEART

Loading

A new procedure for donating hearts and other organs is saving lives. But for some it challenges the definition of death

By Jennifer Couzin-Frankel

On a chilly holiday Monday in January 2020, a medical milestone passed largely unnoticed. In a New York City operating room, surgeons gently removed the heart from a 43-year-old man who had died and shuttled it steps away to a patient in desperate need of a new one.

More than 3500 people in the United States receive a new heart each year. But this case was different—the first of its kind in the country. Read the full article in Science.

Loading

U-M study may help identify patients needing liver transplants

Loading

by Mary Corey

A recent study conducted by a team of University of Michigan medical researchers may help to identify which patients suffering from acute liver failure need liver transplants to live and which can survive without them, helping hospitals more effectively allocate organ donations. With the overall mortality rate of acute liver failure reaching almost 50%, the researchers set out to find a way to tell which patients most urgently need a liver transplant and which can likely survive without. Read more in The Michigan Daily.

Loading

Reflection on Life 10 Years After Stem Cell Transplant

Loading

By Robert Trebor

A decade ago, I was diagnosed with acute myeloid leukemia and underwent aggressive chemotherapy and an allogenic stem cell transplant. Though I still have complications related to my cancer, I’m thankful for what I still have.

I’m still alive. This was not a given 10 years ago, when I was diagnosed with an aggressive case of acute myeloid leukemia (AML).

The usual chemo for AML was applied, but after a few weeks of remission I relapsed, confounding my oncologists. Read the full story in Cure Today.

Loading

Algorithm may help avoid 40% of kidney transplant rejection misdiagnoses: study

Loading

By Nick Paul Taylor

Dive Brief:

  • An algorithm could help pathologists avoid 40% of misdiagnoses of organ transplant rejection and improve patient risk stratification, according to a paper published in Nature Medicine.
  • The decision-support system automatically diagnoses the status of kidney transplants based on the criteria physicians use to determine if a patient is rejecting an organ. Applied to two clinical trials, the algorithm reclassified rejection diagnoses made by pathologists.
    Read the full article in MedTech Dive.
Loading